Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Therapeutic Type
Oligonucleotides Market Set to Reach USD 15.8 Billion by 2036 as RNA Therapeutics and Precision Medicine Accelerate Demand
The oligonucleotides market is emerging as a strategically important segment of biotechnology, pharmaceuticals, diagnostics, and genomic research. Oligonucleotides are short DNA or RNA sequences engineered to interact with specific genetic targets. Their ability to influence RNA expression makes them valuable for antisense therapies, small interfering RNA (siRNA), molecular diagnostics, drug discovery, and precision medicine.
Mtpe Device Market Size, Share, Growth, Analysis, Report, 2034
Mtpe Device Market Size, Share, Growth, Analysis, Report, 2034 2026-08-18 02:31:00 (MENAFN- Straits Research) Market Overview The global mtpe device market size was valued at USD 27.78 billion in 2025 and is projected to grow from USD 29.89 billion in 2026 to USD 53.71 billion by 2034, registering a CAGR of 7.6% during the forecast period from 2026 to 2034. North America dominated the mtpe device market with a market share of 38.5% in 2025.
Squamous Non-Small Cell Lung Cancer Market by Therapeutic Type, Drug Class, Treatment Line, End-User, Geographical Regions, and Leading Players - Trends and Forecast Till 2035
SQUAMOUS NON-SMALL CELL LUNG CANCER MARKET: OVERVIEW As per Roots Analysis, the global squamous non-small cell lung cancer market is estimated to grow from USD 10.0 billion in the current year to USD 18.3 billion by 2035, registering a CAGR of 7.9% across the forecast period. Squamous Non-Small Cell Lung Cancer Market: Growth and Trends Squamous non-small cell lung cancer (NSCLC) is a distinct histologic subtype of NSCLC that arises from the squamous cells lining the larger airways.
United States Narcolepsy Drugs Market to Reach US$ 2,233.56 Million by 2034 - 7.88% CAGR Driven by Novel Therapies and Better Diagnosis
United States Narcolepsy Drugs Market Size and Forecast 2026-2034 United States Narcolepsy Drugs Market is expected to reach US$ 2,409.56 Million by 2034 from US$ 1,217.50 Million in 2025, with a CAGR of 7.88% from 2026 to 2034. United States narcolepsy drugs market growth is driven by increasing diagnosis, rising sleep disorder awareness, advanced therapies, healthcare innovation, improved treatment accessibility, and growing demand for effective symptom management.
Why the Pain Management Market Is Transforming Healthcare Through Precision Medicine, Digital Therapeutics, and Non-Opioid Innovation: Expert View by Spherical Insights
RELEASE DATE: Jul 2026 Author: Spherical Insights According to Spherical Insights & Consulting, the Global Pain Management Market is projected to grow from USD 82.6 billion in 2025 to USD 152.8 billion by 2035, expanding at a CAGR of 6.35% during the forecast period of 2025–2035. Market growth is fueled by the increasing prevalence of chronic pain disorders, an aging global population, rising surgical procedures, expanding cancer care, and growing demand for non-opioid pain therapies.
Infectious Disease Therapeutics Market, By Therapeutic Type, By Disease Indication, By Route of Administration, By Geography
Infectious Disease Therapeutics Market is estimated to be valued at USD 80.04 billion in 2026 and is expected to reach USD 128.52 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.0% from 2026 to 2033.
Antisense Oligonucleotides Market, By Product Type, By Application, By Therapeutic Use, By Geography
Antisense Oligonucleotides Market is estimated to be valued at USD 2.48 billion in 2026 and is expected to reach USD 6.05 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2026 to 2033.
Global Thyroid Eye Disease Treatment Market (2026 Edition)
Description Executive Summary Azoth Analytics has released a research report titled “Global Thyroid Eye Disease Treatment Market (2026 Edition)” which provides a complete analysis of the Global Thyroid Eye Disease Treatment industry in terms of market segmentation By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online...
Clinical Trials Support Service Market to Reach US$ 47.1 Original
Chicago, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The global clinical trials support service market was valued at 25.2 billion in 2023 and is expected to reach US$ 47.1 billion by 2032, growing at a CAGR of 7.22% from 2024 to 2032. The clinical trials support service market is an important backbone to the global healthcare industry. It plays a key role in ushering in innovative treatments and breakthrough therapeutics.
Continuous Manufacturing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
The Global Continuous Manufacturing Market was valued at USD 4.5 billion in 2024 and is estimated to grow at a CAGR of 13.7% to reach USD 16.2 billion by 2034. The market is undergoing expansion as pharmaceutical manufacturers pivot toward faster, scalable, and more reliable production systems. Continuous manufacturing is gaining strong momentum with growing regulatory encouragement and rising demand for more agile drug manufacturing processes.
US Narcolepsy Drugs Market Outlook and Company Analysis Report 2025-2033 Featuring Jazz Pharma, Ligand Pharma, Novartis, Takeda Pharma, Teva, Hikma, Harmony Biosciences, Roche - ResearchAndMarkets.com
The United States Narcolepsy Drugs Market is expected to reach US$ 2.23 billion by 2033 from US$ 1.12 billion in 2024, with a CAGR of 7.88% from 2025 to 2033. The market is expanding mainly due to the growing prevalence of sleep disorders, improved knowledge and diagnosis of narcolepsy, continuous improvements in medication development, and a supportive regulatory environment.
US Narcolepsy Drugs Market Outlook and Company Analysis Report 2025-2033 Featuring Jazz Pharma, Ligand Pharma, Novartis, Takeda Pharma, Teva, Hikma, Harmony Biosciences, Roche - ResearchAndMarkets.com Original
DUBLIN--(BUSINESS WIRE)--The "United States Narcolepsy Drugs Market to Reach US$ 2,233.56 Million by 2033 - 7.88% CAGR Driven by Novel Therapies and Better Diagnosis" report has been added to ResearchAndMarkets.com's offering. The United States Narcolepsy Drugs Market is expected to reach US$ 2.23 billion by 2033 from US$ 1.12 billion in 2024, with a CAGR of 7.88% from 2025 to 2033.
US Narcolepsy Drugs Market Outlook and Company Analysis Report 2025-2033 Featuring Jazz Pharma, Liga
Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet.
Equine Veterinary Therapeutics Market Demand, Size & Forecast 2025 to 2035
Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet.
Can Biotech be Resilient in the Face of Uncertainty?
BDO Biotech Brief - Summer 2025 Introduction This past year brought steady growth to life sciences. The number of biotech IPOs increased slightly in 2024 compared to 2023, allowing the industry to enter 2025 on relatively strong footing. But current political and economic disruption could slow growth, particularly for companies that do not have the cash on hand to weather a delay in fundraising rounds or longer IPO timelines.
Global Clinical Trials Support Service Market to Surpass USD 47.1 Billion by 2032
Astute Analytica’s Global Clinical Trials Support Service Market Report 2024 delivers an in-depth and strategic evaluation of the Clinical Trials Support Service market, offering valuable insights into its evolving landscape. This report explores key dimensions of the market—including its current valuation, forecasted growth, and emerging trends—providing stakeholders with critical intelligence to make informed decisions in an increasingly competitive environment.
Global Clinical Trials Support Service Market to Surpass USD 47.1 Billion by 2032, Growing at a Robust CAGR of 7.22%
Introduction: A Booming Era for Clinical Trials Support Services The Global Clinical Trials Support Service Market is on a fast-paced growth trajectory, having been valued at USD 25.2 billion in 2023. With an increasing emphasis on novel drug development, patient-centric trial models, and digital transformation in healthcare, the market is projected to more than double, reaching USD 47.1 billion by 2032.
Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031)
Azoth Analytics has released a research report titled "Global Thyroid Eye Disease Treatment Market (2025 Edition)" which provides a complete analysis of the Global Thyroid Eye Disease Treatment industry in terms of market segmentation By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Channel) for the historical...
Vietnam Lifestyle Drugs Market Charting Success Future-Proofing Your Business Amidst Market Fluctuations
This country research report on Vietnam Market Reports offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market. The report further elucidates the various factors driving and restraining the market. With both qualitative and quantitative parameters, this is an exhaustive business intelligence report tailored to provide market insights and a detailed segmentation analysis.
Global Clinical Trials Support Service Market to Reach $47.1 Bn by 2032 | 7.22% CAGR
Astute Analytica has released a comprehensive report titled Global Clinical Trials Support Service Market – Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032. This report provides an in-depth examination of the industry, including valuable insights into market analysis, competition, and geographical research. It also highlights recent developments in the global industry.
Lifestyle Drugs Market Advancements Highlighted by Insights and Growth Trends: Leading Players and Future Projections to 2031
[New York, September 2024] Lifestyle drugs encompass a broad category of pharmaceutical and non-pharmaceutical products designed to enhance or maintain a person's quality of life. This includes everything from cognitive enhancers and sexual wellness products to medications that assist with weight management and stress relief.
Mtpe Device Market Report: Analyzing Business Demand Fluctuations and Their Implications, Forecast by 2032
Written by Jayendra G » Updated on: September 25th, 2024 Mtpe Device Industry Executive Summary StraitsResearch has recently added a new report to its vast depository titled Global Mtpe Device Market. The report studies vital factors about the Global Mtpe Device Market that are essential to be understood by existing as well as new market players.
Indian Animal Health Care Market is expected to reach USD 2.07 Bn by 2030
Animal healthcare covers a range of practices, products, and services aimed at promoting and maintaining the health and well-being of animals.
Healthcare Contract Research Organization Market Poised To Reach USD 88.07 Billion By 2031
Healthcare Contract Research Organization Market Poised To Reach USD 88.07 Billion By 2031 6/23/2024 9:08:02 AM (MENAFN- Evertise Digital) -< /> The Healthcare Contract Research Organization market is experiencing significant growth due to a confluence of factors, including increasing investments in R&D programs, a preference for outsourcing clinical trials to save time and money, and the expiration of patents on blockbuster drugs.
Ashland - Local Town Pages
The Healthcare Contract Research Organization Market is experiencing significant growth due to a confluence of factors, including increasing investments in R&D programs, a preference for outsourcing clinical trials to save time and money, and the expiration of patents on blockbuster drugs. The Healthcare Contract Research Organization market, valued at USD 50.5 billion in 2023, is expected to reach USD 88.07 billion by 2031, reflecting a CAGR of 7.2%.
Clinical Trials Support Service Market 2024 Market Insights and Leaders 2032
Astute Analytica recently published a new extensive report on the Global Clinical Trials Support Service Market. The report offers detailed information on the market’s share, size, and projections for key players, applications, product categories, and regions during the forecast period from 2024 to 2032.
Global Clinical Trials Support Service Market Was Valued At US$ 25.2 Billion In 2023 And Is Projected To Surpass US$ 47.1 Billion By 2032 At A CAGR Of 7.22% During The Forecast Period 2024-2032 As Revealed In New Report
Clinical Trials Support Service Market Exploring Projections, Trends, and Opportunities from 2024 to 2032 The global clinical trials support service market, valued at US$ 25.2 billion in 2023, is poised for significant growth in the coming years. With a projected compound annual growth rate (CAGR) of 7.22%, the market is expected to exceed US$ 47.1 billion by 2032.
Crohn’s Disease Therapeutics Market Is Expected To Grow At 5.9 % Through 2024 To 2030, Reaching Nearly US$ 11.16 Bn. As Revealed In New Report
Crohn's disease causes inflammation in various parts of the digestive tract, depending on the individual. Crohn’s Disease Therapeutics Market Overviews Maximize Market Research is an Crohn’s Disease Therapeutics Market research firm that has published a detailed analysis of the “Crohn’s Disease Therapeutics Market ”. MMR's in-depth market assessments in research reports take into account significant technological advancements in the sector.
Forecasting the Growth Trajectory of the Global Clinical Trials Support Service Market In The Latest Research
How Global Clinical Trials Support Services Market Will Reach US$ 47.1 Billion by 2032: Trends and Projections Astute Analytica, a leading provider of market research and analysis, released its highly anticipated Market Analysis Report on the Global Clinical Trials Support Service Market. This comprehensive report aims to equip businesses with invaluable insights and data, enabling them to make informed decisions and stay one step ahead of the competition.
Clinical Trials Support Service Market to Witness a Rise in Revenue of US$ 47.1 Billion By 2032
The global clinical trials support service market was valued at US$ 25.2 billion in 2023 and is projected to surpass US$ 47.1 billion by 2032, growing at a CAGR of 7.22% during the forecast period from 2024 to 2032. The clinical trials support service market is witnessing remarkable growth due to several key factors. These include the increasing complexity of trials, a rise in research and development (R&D) investment, and a growing emphasis on patient-centricity.
Global Clinical Trial Support Service Market to Hit Original
New Delhi, March 06, 2024 (GLOBE NEWSWIRE) -- The global clinical trial support service market was valued at US$ 25.2 billion in 2023 and is expected to reach US$ 47.1 billion by 2032, growing at a CAGR of 7.22% during the forecast period from 2024 to 2032. Strategic support services or the outsourcing of clinical trials to Contract Research Organizations (CROs) marks a pivotal shift in the pharmaceutical research paradigm, ensuring efficiency and cost-effectiveness.
Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent Developments - Forecast to 2030
The global narcolepsy drugs market was valued at US$ 3,596 Million in 2023, and is projected to reach US$ 6,138 Million by 2030. Narcolepsy is a chronic neurological disorder that affects the brain's ability to regulate sleep-wake cycles, resulting in excessive daytime sleepiness (EDS) and, in many cases, cataplexy (sudden loss of muscle control). People suffering from narcolepsy frequently struggle to stay alert for extended periods and experience excessive sleepiness for most of the day.
Navigating the Laryngeal Cancer Therapeutics Market's Growth and Future
The introduction serves as the foundation for our analysis of the Laryngeal Cancer Therapeutics Market. Laryngeal cancer is a formidable challenge within the realm of oncology, characterized by the malignant growth of cells in the larynx or voice box. This form of cancer is of critical concern due to its potential to severely impact an individual's ability to speak, breathe, and swallow, necessitating effective therapeutic solutions.
Catalyzing Medical Breakthroughs: Clinical Trials Support Service Market on Track to Exceed $44.5 Billion Valuation by 2031 | Astute Analytica |
The Global Clinical Trials Support Service Market witnessed a valuation of US$ 23.8 billion in 2022. It is anticipated to exceed US$ 44.5 billion by the year 2031, registering a compound annual growth rate (CAGR) of 7.22% During the Forecast Period From 2023 to 2031. The global clinical trial support services market is going through a remarkable transformation as a result of the increasing revenue share within the industry.
Overview of the Global Clinical Trials Support Service Market
Astute Analytica, a leading provider of market research and analysis, released its highly anticipated Market Analysis Report on the Global Clinical Trials Support Service Market. This comprehensive report aims to equip businesses with invaluable insights and data, enabling them to make informed decisions and stay one step ahead of the competition.
Crohn's Disease Therapeutics Market was valued at USD 7.06 billion in 2022, with a projected growth rate of 5.9% from 2023 to 2029. The market is expected to reach nearly USD 10.55 billion by the end of the forecast period.
Crohn's Disease Therapeutics Market Report Scope and Research Methodology Maximize Market Research Pvt. Ltd., a leading market research company based in Pune, India, has released a comprehensive market research report on the Crohn's Disease Therapeutics Market. The report provides a detailed analysis of the market size, trends, dynamics, and key players in the industry.
Global Thyroid Eye Disease Treatment Market : Analysis By Therapeutic Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast
Azoth Analytics has released a research report titled "Global Thyroid Eye Disease Treatment Market (2023 Edition)" which provides a complete analysis of the global Thyroid Eye Disease Treatment industry in terms of market segmentation by Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, Other Therapeutics), Route of Administration (Oral, Parenteral, Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel), By Region and By Country.
Clinical Trials Support Service Market to Reach a Valuation of US$ 44.5 Billion By 2031: Showing Potential to Expand for Key Players |
Global Clinical Trials Support Service Market size was US$ 23.8 billion in 2022 and is estimated to surpass US$ 44.5 billion by 2031, growing at a CAGR of 7.22% during the forecast period from 2023 to 2031. The clinical trials support services market is expected to grow throughout the projected period. The market is one of the major pillars underpinning the global healthcare sector.
Narcolepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
Narcolepsy Drugs Market size is projected to reach US$ 5.95 Billion by 2030, according to Renub Research.
$11.729 Bn Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities and Strategies to 2032 Featuring Major Players - IBM, Microsoft, NVIDIA, Exscientia, Alphabet, & Atomwis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 21, 2023-- The global artificial intelligence (AI) in drug discovery market reached a value of nearly $1,042.3 million in 2022, having grown at a compound annual growth rate (CAGR) of 30.5% since 2017. The market is expected to grow from $1,042.3 million in 2022 to $3,739.2 million in 2027 at a rate of 29.1%. The market is then expected to grow at a CAGR of 25.7% from 2027 and reach $11,729.1 million in 2032.
Clinical Trials Support Service Market Is Projected To Surpass US$ 44.5 Billion By 2031 | IQVIA, Novotech, Parexel International
The latest research from Astute Analytica, titled “Global Clinical Trials Support Service Market Report and Forecast 2023-2031,” provides a detailed analysis of the market for Clinical Trials Support Service Market globally, evaluating the industry based on its segments, such as services, and main geographical areas.
$11.729 Bn Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities and Strategies to 2032 Featuring Major Players - IBM, Microsoft, NVIDIA, Exscientia, Alphabet, & Atomwis - ResearchAndMarkets.com Original
DUBLIN--()--The "Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering. The global artificial intelligence (AI) in drug discovery market reached a value of nearly $1,042.3 million in 2022, having grown at a compound annual growth rate (CAGR) of 30.5% since 2017. The market is expected to grow from $1,042.3 million in 2022 to $3,739.2 million in 2027 at a rate of 29.1%.
$11.729 Bn Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities and Strategies
Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet.
Healthcare Contract Research Organization Market to Grow Substantially Driven by Increasing R&D Outsourcing and Globalization of Clinical Trials
Healthcare Contract Research Organization Market Scope & Overview As per the SNS Insider report, the Healthcare Contract Research Organization market was assessed at approximately USD 48.15 billion in 2022. It is projected to achieve a valuation of around USD 80.89 billion by the year 2030, exhibiting a CAGR of roughly 6.7% during the forecast period spanning from 2023 to 2030.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Therapeutic
Contact Therapeutic, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack